Effect of Low Glycaemic Index Diet on Blood Glucose Control in Chinese Type 2 Diabetic Patients: Randomized Controlled Trial
试验速览
- 阶段
- 不适用
- 发起方
- 入组人数
- 44
- 试验地点
- 1
- 主要终点
- Change in blood HbA1c
研究概览
简要总结
The purpose of this study is to investigate the effect of low glycaemic diet on blood glucose control in Chinese type 2 diabetic patients.
详细描述
Glycaemic index (GI) is the measurement of post-meal blood glucose rise cause by ingestion of carbohydrate. For the same amount of carbohydrate, food with lower GI value cause a lower post- meal rise in blood glucose concentration in both normal and diabetic patients. Meta-analysis of randomized controlled trial has showed that low GI diet can achieve an additional reduction of A1c by 0.4% when compare with usual diabetic diet. Furthermore, various diabetes associations have already endorsed the use of low GI diet in the management of diabetes.
Hong Kong Chinese obtain most of their carbohydrate intake through consumption of rice or rice related foods, which are considered as having high GI value. In addition, it has been demonstrated that Asian have higher post-prandial rise in blood glucose than Caucasian after consuming the same amount of carbohydrate. When the above two factors add together, we expect our local type 2 diabetic patients are suffering from significant post-prandial hyperglycaemia, which in turn translate into elevated 24-hour hyperglycaemia and A1c.
However, nearly all studies about glycaemic index and diabetes are conducted in Caucasian. It is unclear about the benefit in Chinese patients with type 2 diabetes who are currently having diet with high GI value.
We therefore hypothesized that low GI diet may improve blood glucose control in Chinese type 2 diabetic patients. To test this hypothesis, we plan to conduct this randomized controlled trial about low GI diet in Chinese diabetic patients.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Chinese Type 2 diabetic patient.
- •Already performing self monitoring blood glucose ( SMBG ) with pre- and post-meal readings.
- •At least 50% of 2hr post-meal capillary blood glucose values are > 9 mmol/L.
- •A1c between 7.0 to 8.0% within 2 weeks of randomization.
- •Next follow-up is scheduled to at least 12 weeks or more if currently follow-up in TWEH.
- •On stable dose of anti-diabetic drug in the preceding 10 weeks.
- •No change in anti-DM drug in the next 10 week.
- •At least 18 years old.
- •Can read and understand consent form written in Chinese.
- •Can give informed consent.
排除标准
- •Unexplained hypoglycaemia in last 4 weeks.
- •Using rapid onset insulin ( such as Humalog, Novorapid, Actrapid HM, Mixtard HM, Novomix and Humalog Mix ).
- •Using acarbose.
- •Known thalassaemia.
- •Suspected or confirmed iron deficiency.
- •On warfarin.
- •Renal impairment with serum creatinine > 150 umol/L
- •Active medical illness, such as hepatitis, malignancy, infection, inflammatory arthritis, etc.
- •Unable to follow low glycaemic index diet.
- •Currently participate in other study.
- •Mentally or cognitively disable.
- •Pregnant or lactating women.
- •Hospital Authority or TWEH staff.
结局指标
主要结局
Change in blood HbA1c
时间窗: Baseline and week 10
次要结局
- Change in pre- and 2-hour post-meal capillary blood glucose concentration(Baseline and week 10)
- Change in fasting blood glucose(Baseline and week 10)
- Change in lipid profile ( total cholesterol, triglycerides, LDL-C, HDL-C )(Baseline and week 10)
- Change in blood ALT(Baseline and week 10)
- Change in body weight(Baseline and week 10)
- Change in blood pressure(Baseline and week 10)
研究者
Ace Lee
Doctor
Hospital Authority, Hong Kong